title: Special issues in myeloproliferative neoplasms.
abstract: Special issues in myeloproliferative neoplasms (MPN) comprise clinical conditions with high relevance for the duration and quality of the patient's life, but with limited evidence to support sound diagnostic and therapeutic recommendations and a low probability of being solved by the current standard of clinical research. These issues include MPN in pregnancy and in children, abdominal vein thrombosis, bleeding complications, surgery, pruritus, and leukemic transformation. Practical suggestions to guide clinical decisions in these settings remain largely empirical, but recently developed guidelines based on experts' consensus may help to tackle these problems. This article reviews the state of the art regarding these issues, with special emphasis on experts' consensus recommendations.
authors.affiliation: Research Foundation, Ospedali Riuniti, Via Garibaldi 13, 24124, Bergamo, Italy. tbarbui@ospedaliriuniti.bergamo.it
authors.forename: Tiziano
authors.initials: T
authors.lastname: Barbui
authors.forename: Guido
authors.initials: G
authors.lastname: Finazzi
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D002471:Cell Transformation, Neoplastic / Q000473:pathology; D002648:Child; D005260:Female; D006470:Hemorrhage / Q000150:complications; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D009196:Myeloproliferative Disorders / Q000150:complications* / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D011247:Pregnancy; D011537:Pruritus / Q000150:complications; D020246:Venous Thrombosis / Q000150:complications
chemical_list: D000970:Antineoplastic Agents; D006918:Hydroxyurea